POSTERS ESMO 2024

Tumores neuroendocrinos

Retreatment with peptide receptor radionuclide therapy (PRRT) in patients (p) with neuroendocrine tumors (NET): Spanish clinical experience from SEPTRALU national registry.

Retreatment with peptide receptor radionuclide therapy (PRRT) in patients (p) with neuroendocrine tumors (NET): Spanish clinical experience from SEPTRALU national registry.

Poster Bd #: 1157P

Poster

Descargar poster

Autor
Jorge Hernando Cubero

Hospital Universitario Vall d’Hebron. Barcelona

Compartir:

Una iniciativa científica de:

eco clover

Con el patrocinio de:

REGENERON